16
Jun
2026
Small Molecules To Correct Disease: Sri Kosuri on The Long Run
Sri Kosuri is today’s guest on The Long Run. Sri is the co-founder and CEO of Emeryville, California-based Octant Bio. The company is developing oral small molecule drugs that are designed to correct protein misfolding and mistrafficking. Quite a few rare diseases, cancers, and metabolic disorders are thought to be amenable to this strategy. Octant’s work starts with a platform... Read More